SGCB and pulmonary hypertension: Cinaciguat, a soluble guanylyl cyclase (sGC) activator, could activate heme-deficient sGC to increase intracellular cyclic guanosine monophosphate (cGMP) for further biological effects and is currently used in patients with pulmonary hypertension (Evgenov et al., 2006).